ECSTACY: A Review of MDMA and MDA
The International Journal of Psychiatry in Medicine December 1, 1987 Robert P. Climko, Herbert Roehrich, Donald R. Sweeney et al. 77 citations
The Drug Enforcement Administration classified MDMA (Ecstasy) as a Schedule I controlled substance in 1985 amid controversy over its potential as a psychotherapy aid and broader debates on regulating designer drugs. The authors review literature on MDMA and its chemical predecessor MDA, which differs by one methyl group, examining the evidence behind the scheduling decision.